These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 25546793)

  • 41. [Thymectomy in myasthenia gravis (author's transl)].
    Gschnitzer F
    Z Erkr Atmungsorgane; 1975 Mar; 142(3):284-9. PubMed ID: 1226892
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Therapy in myasthenia gravis and Lambert-Eaton myasthenic syndrome.
    Newsom-Davis J
    Semin Neurol; 2003 Jun; 23(2):191-8. PubMed ID: 12894384
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic factors for myasthenic crisis after transsternal thymectomy in patients with myasthenia gravis.
    Watanabe A; Watanabe T; Obama T; Mawatari T; Ohsawa H; Ichimiya Y; Takahashi N; Kusajima K; Abe T
    J Thorac Cardiovasc Surg; 2004 Mar; 127(3):868-76. PubMed ID: 15001919
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High-dose intravenous immunoglobulin for the treatment of MuSK antibody-positive seronegative myasthenia gravis.
    Takahashi H; Kawaguchi N; Nemoto Y; Hattori T
    J Neurol Sci; 2006 Sep; 247(2):239-41. PubMed ID: 16876198
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Simultaneous operation for multiple valvular disease and myasthenia in a woman.
    Wang Q; Xu Z; Lin B; Lu F; Cui Y
    Heart Lung Circ; 2011 Feb; 20(2):130-1. PubMed ID: 20810314
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Myasthenic crisis after a renal transplant successfully treated with intravenous immunoglobulin.
    Hwang IH; Lee KN; Kim IY; Lee DW; Lee SB; Kim DS; Song SH; Seong EY; Kwak IS
    Exp Clin Transplant; 2014 Dec; 12(6):555-8. PubMed ID: 24568644
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intravenous immunoglobulin-induced hemolytic anemia after thoracoscopic thymectomy for myasthenia gravis.
    Tsukada H; Sunkara R; Chi DD; Keogh D; Gaissert H
    Ann Thorac Surg; 2014 Jun; 97(6):2175-7. PubMed ID: 24882299
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Randomized, controlled trial of intravenous immunoglobulin in myasthenia gravis.
    Wolfe GI; Barohn RJ; Foster BM; Jackson CE; Kissel JT; Day JW; Thornton CA; Nations SP; Bryan WW; Amato AA; Freimer ML; Parry GJ;
    Muscle Nerve; 2002 Oct; 26(4):549-52. PubMed ID: 12362423
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Robotic thymectomy in patients with myasthenia gravis: neurological and surgical outcomes.
    Keijzers M; de Baets M; Hochstenbag M; Abdul-Hamid M; Zur Hausen A; van der Linden M; Kuks J; Verschuuren J; Kessels F; Dingemans AM; Maessen J
    Eur J Cardiothorac Surg; 2015 Jul; 48(1):40-5. PubMed ID: 25234092
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Plasma exchange for treatment of myasthenia gravis: pathophysiologic basis and clinical experience.
    Qureshi AI; Suri MF
    Ther Apher; 2000 Aug; 4(4):280-6. PubMed ID: 10975474
    [TBL] [Abstract][Full Text] [Related]  

  • 51. International consensus guidance for management of myasthenia gravis: Executive summary.
    Sanders DB; Wolfe GI; Benatar M; Evoli A; Gilhus NE; Illa I; Kuntz N; Massey JM; Melms A; Murai H; Nicolle M; Palace J; Richman DP; Verschuuren J; Narayanaswami P
    Neurology; 2016 Jul; 87(4):419-25. PubMed ID: 27358333
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Various aspects of intensive therapy in myasthenia gravis].
    Villani A; De Cosmo G; Scrascia E
    Minerva Anestesiol; 1981 Dec; 47(12):891-900. PubMed ID: 7335193
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Myasthenia Gravis.
    Gilhus NE
    N Engl J Med; 2016 Dec; 375(26):2570-2581. PubMed ID: 28029925
    [No Abstract]   [Full Text] [Related]  

  • 54. The course of myasthenia gravis with systemic lupus erythematosus.
    Bekircan-Kurt CE; Tuncer Kurne A; Erdem-Ozdamar S; Kalyoncu U; Karabudak R; Tan E
    Eur Neurol; 2014; 72(5-6):326-9. PubMed ID: 25323839
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Clinical characteristics and managements of juvenile myasthenia gravis].
    Ishigaki K
    Nihon Rinsho; 2015 Sep; 73 Suppl 7():533-8. PubMed ID: 26480755
    [No Abstract]   [Full Text] [Related]  

  • 56. Continuous tracheal intubation in patients with myasthenia gravis after thymectomy to prevent tracheal incision for myasthenic crisis.
    Deng B; Ma Z; Jiang YG; Wang RW; Tan QY; Zhao YP; Zhou JH; Gong TQ
    J Thorac Cardiovasc Surg; 2011 Jul; 142(1):240; author reply 240-1. PubMed ID: 21683846
    [No Abstract]   [Full Text] [Related]  

  • 57. Intravenous immunoglobulin to prevent myasthenic crisis after thymectomy and other procedures can be omitted in patients with well-controlled myasthenia gravis.
    Gamez J; Salvadó M; Carmona F; de Nadal M; Romero L; Ruiz D; Jáuregui A; Martínez O; Pérez J; Suñé P; Deu M
    Ther Adv Neurol Disord; 2019; 12():1756286419864497. PubMed ID: 31360225
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Myasthenia gravis].
    Fleury MC; Tranchant C
    Rev Prat; 2008 Dec; 58(20):2217-24. PubMed ID: 19209651
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of myasthenia gravis with high-dose intravenous immunoglobulin.
    Cosi V; Lombardi M; Piccolo G; Erbetta A
    Acta Neurol Scand; 1991 Aug; 84(2):81-4. PubMed ID: 1950455
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cellular immunity following video-assisted thoracoscopic and open resection for non-thymomatous myasthenia gravis.
    Chen Z; Zuo J; Zou J; Sun Y; Liu W; Lai Y; Zhong B; Su C; Tan M; Luo H
    Eur J Cardiothorac Surg; 2014 Apr; 45(4):646-51. PubMed ID: 24005161
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.